In this review, we will summarize the current evidence elucidating the pivotal role of RB1 in orchestrating both biological and pathological mechanisms across diverse cancer types, which not only enhances our understanding of the intricate molecular landscape due to RB1 loss but also lays the groundwork for the rational design of targeted therapeutic drugs. The gene discussed is RB1; the disease is cancer.